List of GLP-1 receptor agonists: difference between revisions
Diff·revision 4 → 5·22:20, 19 Sep 2024
Difference between revision 4 and revision 5 of List of GLP-1 receptor agonists. 4 lines changed; the page grew by 373 bytes.
| Revision 4 — 21:04, 3 Sep 2024 NavboxNiko (talk) add the category the list itself belongs in 1,884 bytes ±0 | Revision 5 — 22:20, 19 Sep 2024 CiteBot (talk) bot: sort category members 2,257 bytes +373 | ||
|---|---|---|---|
| 9 | Status is given as approved or investigational without specifying jurisdiction, since approval differs between countries. See [[Regulatory status by jurisdiction]].{{r|ada2024}} | 9 | Status is given as approved or investigational without specifying jurisdiction, since approval differs between countries. See [[Regulatory status by jurisdiction]].{{r|ada2024}} |
| 10 | 10 | ||
| + | 11 | Compounds appearing here are covered by their own articles where one exists. Inclusion is not an endorsement, and several entries are investigational compounds not approved anywhere.{{r|usp1503}} | |
| + | 12 | ||
| 11 | == GLP-1 receptor agonists == | 13 | == GLP-1 receptor agonists == |
| 12 | | Compound | Route | Interval | Status | | 14 | | Compound | Route | Interval | Status | |
| ⋮ | ⋮ | ||
| 26 | <ref name="drucker2018">Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." ''Cell Metabolism'' 27(4):740–756 (2018). PMID 29617641.</ref> | 28 | <ref name="drucker2018">Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." ''Cell Metabolism'' 27(4):740–756 (2018). PMID 29617641.</ref> |
| 27 | <ref name="ada2024">American Diabetes Association. "Standards of Care in Diabetes." ''Diabetes Care'' 47(Suppl 1) (2024).</ref> | 29 | <ref name="ada2024">American Diabetes Association. "Standards of Care in Diabetes." ''Diabetes Care'' 47(Suppl 1) (2024).</ref> |
| + | 30 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | |
| 28 | 31 | ||
| 29 | {{DEFAULTSORT:List of GLP-1 receptor agonists}} | 32 | {{DEFAULTSORT:List of GLP-1 receptor agonists}} |
| 30 | [[Category:Lists]] | 33 | [[Category:Lists]] |
| 31 | [[Category:Reference material]] | 34 | [[Category:Reference material]] |
| + | 35 | [[Category:GLP-1 receptor agonists]] | |
| 32 | 36 |